A large number of institutions have started programs banking umbilical cord blood (UCB) for allogeneic unrelated-donor and related-donor transplantation.
However, limited information is available on the financial issues surrounding these activities.
The aim of this study was to determine the fee per UCB unit released for transplantation that would allow cost recovery after 10 years.
Three organizational models were considered suitable to provide units for five UCB transplants per 1 million population per year, a figure that would translate into an annual need for 280 units in Italy.
Models A, B, and C included, respectively, seven networked banks, each with an inventory of 1,500 units ; two networked banks, each with an inventory of 5,000 units ; and one bank with an inventory of 10,000 units.
It was estimated that it would take 3 years to develop the cryopreserved inventory and that approximately 3 percent of the inventory could be released and replaced each year during the 7-year interval between the fourth and tenth years of activity.
The data on the costs of labor, reagents and diagnostics, disposables, depreciation and maintenance, laboratory tests, and overhead, as well as the operational data used in the analysis were collected at the Milano Cord Blood Bank in 1996. (...)
Mots-clés Pascal : Homogreffe, Cellule souche, Cordon ombilical, Conservation, Sang, Coût, Traitement, Homme, Greffe, Economie santé
Mots-clés Pascal anglais : Homograft, Stem cell, Umbilical cord, Conservation, Blood, Costs, Treatment, Human, Graft, Health economy
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0364227
Code Inist : 002B27D02. Création : 14/12/1999.